Brain-targeted β‐hydroxy-β‐methylbutyrate administration in the prevention of insulin resistance development in the hypothalamus and cerebral cortex of rats fed high-fat diet

2022/47/D/NZ7/00429

Keywords

Descriptors

  • NZ7_012: Prewencja chorób człowieka

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Medyczny w Białymstoku

Voivodeship: podlaskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Elżbieta Supruniuk

Number of co-investigators in the project: 4

Call

SONATA 18 – announced on 2022-07-15

Amount awarded
1 354 240 PLN
Project start date
2023-07-06
Project end date
2026-07-05
Project duration
36 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski